Table 1.
General Information and Model Characteristics of Studies Using Quantitative Benefit-Risk Models for Rotavirus Vaccination
| General Information | Model Characteristics | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Source | Vaccine(s) | Alternative(s) | Funding | Income Category | Simulation Model | Static/ Dynamic Model | Herd Effect | Waning Effect | Closed / Open Model | Deterministic/ Probabilistic Model | Aggregate/ Individual- Based Model | Scenario/ Sensitivity Analyses |
| Patel et al [42] | Rotarix/RotaTeq | No vaccination No age restriction to vaccination | Other | LMICs | No | Static | No | No | Closed | Deterministic | Aggregate | Scenario |
| Patel et al [18] | Rotarix | No vaccination | Other | LMICs | No | Static | No | No | Closed | Deterministic | Aggregate | No |
| Desai et al [39] | Rotarix/RotaTeq | No vaccination | Other | LMICs | Yes | Static | No | No | Closed | Probabilistic | Aggregate | PSA |
| Patel et al [43] | Rotarix/RotaTeq | No vaccination No age restriction to vaccination | Other | LMICs | Yes | Static | No | No | Closed | Probabilistic | Aggregate | Scenario PSA |
| Carlin et al [17] | Rotarix/RotaTeq | No vaccination | Other | HIC | No | Static | No | No | Closed | Deterministic | Aggregate | No |
| Desai et al [38] | RotaTeq | No vaccination | Other | HIC | Yes | Static | No | No | Closed | Probabilistic | Aggregate | DSA/PSA |
| Clark et al [37] | Rotarix | No vaccination No age restriction to vaccination | Other | HIC | Yes | Static | No | Yes | Closed | Probabilistic | Aggregate | Scenario PSA |
| Yung et al [44] | Rotarix | No vaccination | Other | HIC | No | Static | No | No | Closed | Deterministic | Aggregate | Scenario |
| Ledent et al [41] | Rotarix | No vaccination | Pharma ceutical | HIC | Yes | Static | No | No | Closed | Probabilistic | Aggregate | DSA/PSA |
| Lamrani et al [40] | Rotarix/RotaTeq | No vaccination | Other | HIC | Yes | Static | No | Yes | Closed | Probabilistic | Aggregate | Scenario PSA |
| Ledent et al [48] | Rotarix | No vaccination | Pharma ceutical | HIC | Yes | Static | No | No | Closed | Probabilistic | Aggregate | DSA/PSA Scenario |
| Bruijning-Verhagen et al [45] | RotaTeq | No vaccination Targeted vaccination | Other | HIC | Yes | Static | Yes | Yes | Closed | Probabilistic | Aggregate | DSA/PSA Scenario |
| Bruun et al [46] | Rotarix | No vaccination No age restriction to vaccination | Other | HIC | No | Static | No | Yes | Closed | Deterministic | Aggregate | Scenario |
| Clark et al [47] | Rotarix/RotaTeq/ RV3-BB/ROTAVAC/ROTASIIL | No vaccination No age restriction to vaccination | Other | LMICs | Yes | Static | No | Yes | Closed | Probabilistic | Aggregate | PSA Scenario |
Abbreviations: DSA, deterministic sensitivity analyses; HIC, high-income country; LMICs, low- and middle-income countries; PSA, probabilistic sensitivity analyses.